Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Valensa Granted U.S. Patents on Omega-3 Perilla Seed Compositions - Nutraceuticals World

What are you searching for?

Sign in
Regulations

Valensa Granted U.S. Patents on Omega-3 Perilla Seed Compositions

By: Lisa Olivo

, Rodman Media

Valensa International, Orlando, FL, has received a series of patents covering the composition and application of nutraceutical formulations featuring Perilla seed oil as a major component. The most important of these new patents is one that covers the use of Perilla seed oil alone or in combination with other omega-3 sources such as krill oil, algae oils, fish oils and other seed oils for cardiovascular health support.
 
Recent research points to the importance of a lowered omega-6/omega-3 ratio and its impact on chronic inflammation in the body as a major contributor to better cardiovascular health. Numerous studies have shown that a high omega-6/omega-3 ratio increases the risk of heart attacks and stroke by as much as 30%. With an omega-3 to omega-6 ratio of 6:1 — the highest naturally occurring seed-based ratio in nature — Perilla seed oil is an ideal way to address the omega-6/omega-3 imbalance which is common to Western diets, said the company.
 
Valensa markets a range of supercritical CO2 extract Perilla-based formulations including Verilla Perilla Seed Extract, Kerilla Perilla Seed Extract + Krill Oil, VerillaMax Perilla Seed Flour, Zanthin Xp-3 Perilla seed extract with astaxanthin and Z-Omega 3-6-9 — a combination of chia seed extract, Perilla seed extract and olive extract. The company plans to utilize this new intellectual property in a range of new formulated products.
 
According to Dr. Rudi E. Moerck, President & CEO of Valensa, new research on the vegan and vegetarian communities is starting to bring the role of different types of omega-3 fatty acids the cardiovascular health into better focus. “Recent research has shown us that cardiovascular mortality rates for vegans and vegetarians are higher than those who consume a Western-type meat-based diet — despite the positive impact that vegan/vegetarian diets have on important CVD markers. Even newer research points us to why this may be the case. Vegetarians —and even more so vegans — have a very high omega-6 to omega-3 fatty acid ratio in their systems — up to 15 to 17:1 and science tells us that this number needs to be closer to 4:1. These high ratios stimulate the production of arachidonic acid (AA) which greatly increases inflammation in the body, which cam lead  to a number of different chronic health conditions — particularly cardiovascular disease and strokes,” he said. “Perilla seed oil is a remarkable natural substance because of its omega-3/omega-6 composition of 6:1 its containing up to 60% alphalinolenic acid (ALA). We’re excited about the opportunity to develop a range of new Perilla-based formulations for cardiovascular support – particularly as we begin to refine our understanding of the benefits of different marine and algae-based Omega-3s in supplying EPA/DHA and how they can work together with Perilla to create revolutionary formulations for cardiovascular support,” he said.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics